Retour
22
Fourchette du Jour
31,77 €
33,62 €
Fourchette 52 Semaines
25,08 €
66,03 €
Volume
6 472 450
Moyenne 50J / 200J
41,89 €
/
37,93 €
Clôture Précédente
32,98 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -2,4 | 0,2 |
| P/B | 0,8 | 3,0 |
| ROE % | -28,8 | 3,6 |
| Net Margin % | -3,4 | 3,8 |
| Rev Growth 5Y % | 11,5 | 10,0 |
| D/E | 0,9 | 0,2 |
Objectif de Cours des Analystes
Hold
44,90 €
+37.2%
Low: 38,00 €
High: 59,00 €
P/E Prévisionnel
10,97
BPA Prévisionnel
2,98 €
Croissance BPA (est.)
+0,0%
CA Est.
189,80B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
8,79 €
8,42 € – 9,22 €
|
200,38B | 1 |
| FY2029 |
8,23 €
7,88 € – 8,63 €
|
196,32B | 1 |
| FY2028 |
5,61 €
5,29 € – 6,01 €
|
195,76B | 3 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-06 | -1,22 € | -1,19 € | +2,5% |
| 2025-10-29 | -0,14 € | 0,50 € | +445,4% |
| 2025-07-25 | 0,11 € | -0,16 € | -243,4% |
| 2025-04-25 | 2,52 € | 2,90 € | +15,1% |
| 2025-02-04 | 0,44 € | 0,80 € | +81,8% |
| 2024-10-25 | 1,33 € | 1,62 € | +21,8% |
| 2024-07-26 | 2,07 € | 2,42 € | +16,9% |
| 2024-04-26 | 2,08 € | 2,26 € | +8,7% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 11,51% annually over 5 years — strong growth
Earnings declined -301,91% over the past year
Generating 4,32B in free cash flow
PEG of 0,01 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 7,93%
Capital efficient — spends only 0,39% of revenue on capex
Croissance
Revenue Growth (5Y)
11,51%
Revenue (1Y)19,44%
Earnings (1Y)-301,91%
FCF Growth (3Y)-22,82%
Qualité
Return on Equity
-28,79%
ROIC-14,75%
Net Margin-3,43%
Op. Margin-3,91%
Sécurité
Debt / Equity
0,94
Current Ratio1,68
Interest Coverage-11,24
Valorisation
P/E Ratio
-2,41
Forward P/E10,97
P/B Ratio0,81
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 19,44% | Revenue Growth (3Y) | 12,46% |
| Earnings Growth (1Y) | -301,91% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 11,51% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 194,78B | Net Income (TTM) | -6,67B |
| ROE | -28,79% | ROA | -8,59% |
| Gross Margin | 12,24% | Operating Margin | -3,91% |
| Net Margin | -3,43% | Free Cash Flow (TTM) | 4,32B |
| ROIC | -14,75% | FCF Growth (3Y) | -22,82% |
| Safety | |||
| Debt / Equity | 0,94 | Current Ratio | 1,68 |
| Interest Coverage | -11,24 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2,41 | Forward P/E | 10,97 |
| P/B Ratio | 0,81 | P/S Ratio | 0,08 |
| PEG Ratio | 0,01 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | 4,20 |
| Forward P/S | 0,08 | Fwd Earnings Yield | 9,12% |
| FCF Yield | 26,85% | ||
| Market Cap | 16,09B | Enterprise Value | 16,98B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 194,78B | 163,07B | 154,00B | 144,55B | 125,98B |
| Net Income | -6,67B | 3,31B | 2,70B | 1,20B | 1,35B |
| EPS (Diluted) | -13,62 | 6,31 | 4,95 | 2,07 | 2,28 |
| Gross Profit | 23,83B | 16,83B | 17,32B | 16,66B | 14,20B |
| Operating Income | -7,62B | 3,18B | 2,93B | 1,32B | 1,78B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 77,66B | 82,45B | 84,64B | 76,87B | 78,38B |
| Total Liabilities | 57,61B | 55,94B | 58,69B | 52,63B | 51,35B |
| Shareholders' Equity | 19,95B | 26,41B | 25,84B | 24,06B | 26,80B |
| Total Debt | 18,78B | 19,43B | 18,88B | 21,33B | 22,66B |
| Cash & Equivalents | 17,89B | 14,06B | 17,19B | 12,07B | 13,12B |
| Current Assets | 35,99B | 38,00B | 40,76B | 30,13B | 28,50B |
| Current Liabilities | 21,48B | 34,26B | 36,72B | 28,46B | 25,77B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#433 of 619
Activité Récente
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026